{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:43:18Z","timestamp":1792478598374,"version":"4.5.0"},"reference-count":42,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15852","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:56:49Z","timestamp":1788868609000},"page":"1-13","source":"Crossref","is-referenced-by-count":0,"title":["Integrated bioinformatics and feature selection-based discovery of ADP-ribosylation-associated biomarkers in non-small cell lung cancer"],"prefix":"10.3892","volume":"32","author":[{"given":"Jie","family":"He","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, Hebei General Hospital, Shijiazhuang, Hebei 050057, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingtao","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Hebei General Hospital, Shijiazhuang, Hebei 050057, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhen","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Hebei General Hospital, Shijiazhuang, Hebei 050057, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Hebei General Hospital, Shijiazhuang, Hebei 050057, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghui","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Hebei General Hospital, Shijiazhuang, Hebei 050057, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxin","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Hebei General Hospital, Shijiazhuang, Hebei 050057, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengming","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Hebei General Hospital, Shijiazhuang, Hebei 050057, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghong","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Pediatric Research, Children's Hospital of Hebei Province, Shijiazhuang, Hebei 050000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Research, Children's Hospital of Hebei Province, Shijiazhuang, Hebei 050000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shicheng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Hebei General Hospital, Shijiazhuang, Hebei 050057, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"key20261020093159_b1-ol-32-5-15852","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"key20261020093159_b2-ol-32-5-15852","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J Natl Cancer Cent"},{"key":"key20261020093159_b3-ol-32-5-15852","first-page":"203","article-title":"Cancer survival statistics in China 2019\u20132021: A multicenter, population-based study","volume":"4","author":"Zeng","year":"2024","journal-title":"J Natl Cancer Cent"},{"key":"key20261020093159_b4-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.molmed.2019.04.012","article-title":"Abandoning the notion of non-small cell lung cancer","volume":"25","author":"Relli","year":"2019","journal-title":"Trends Mol Med"},{"key":"key20261020093159_b5-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13045-019-0762-1","article-title":"Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma","volume":"12","author":"Jiang","year":"2019","journal-title":"J Hematol Oncol"},{"key":"key20261020093159_b6-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1038\/s41467-019-11452-x","article-title":"Proteogenomic landscape of squamous cell lung cancer","volume":"10","author":"Stewart","year":"2019","journal-title":"Nat Commun"},{"key":"key20261020093159_b7-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3390\/ijms22020612","article-title":"Molecular epidemiology of the main druggable genetic alterations in non-small cell lung cancer","volume":"22","author":"Fois","year":"2021","journal-title":"Int J Mol Sci"},{"key":"key20261020093159_b8-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1056\/NEJMoa2304594","article-title":"Overall survival with osimertinib in resected EGFR-mutated NSCLC","volume":"389","author":"Tsuboi","year":"2023","journal-title":"N Engl J Med"},{"key":"key20261020093159_b9-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1042\/BCJ20210280","article-title":"Beyond protein modification: The rise of non-canonical ADP-ribosylation","volume":"479","author":"Schuller","year":"2022","journal-title":"Biochem J"},{"key":"key20261020093159_b10-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1021\/acs.chemrev.7b00122","article-title":"ADP-ribosylation, a multifaceted posttranslational modification involved in the control of cell physiology in health and disease","volume":"118","author":"L\u00fcscher","year":"2018","journal-title":"Chem Rev"},{"key":"key20261020093159_b11-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1161\/ATVBAHA.124.321682","article-title":"PARylation of POLG mediated by PARP1 accelerates ferroptosis-induced vascular calcification via activating Adora2a\/Rap1 signaling","volume":"45","author":"Yang","year":"2025","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20261020093159_b12-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"111073","DOI":"10.1016\/j.cellsig.2024.111073","article-title":"Deciphering the immunological and prognostic features of hepatocellular carcinoma through ADP-ribosylation-related genes analysis and identify potential therapeutic target ARFIP2","volume":"117","author":"Jiang","year":"2024","journal-title":"Cell Signal"},{"key":"key20261020093159_b13-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/s43018-025-00986-3","article-title":"The tumor microenvironment's role in the response to immune checkpoint blockade","volume":"6","author":"Aliazis","year":"2025","journal-title":"Nat Cancer"},{"key":"key20261020093159_b14-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","article-title":"Immune evasion in cancer: Mechanisms and cutting-edge therapeutic approaches","volume":"10","author":"Tufail","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"key20261020093159_b15-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"150066","DOI":"10.1016\/j.bbrc.2024.150066","article-title":"CD47-mediated immune evasion in early-stage lung cancer progression","volume":"720","author":"Chuang","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"key20261020093159_b16-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/S1470-2045(19)30388-2","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): Post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study","volume":"20","author":"Robert","year":"2019","journal-title":"Lancet Oncol"},{"key":"key20261020093159_b17-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1038\/s44318-024-00125-1","article-title":"PARP14 is regulated by the PARP9\/DTX3L complex and promotes interferon \u03b3-induced ADP-ribosylation","volume":"43","author":"Ribeiro","year":"2024","journal-title":"Embo J"},{"key":"key20261020093159_b18-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.molcel.2023.04.009","article-title":"PARPs and ADP-ribosylation: Deciphering the complexity with molecular tools","volume":"83","author":"Dasovich","year":"2023","journal-title":"Mol Cell"},{"key":"key20261020093159_b19-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"key20261020093159_b20-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: An R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"key20261020093159_b21-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"e0206239","DOI":"10.1371\/journal.pone.0206239","article-title":"miRWalk: An online resource for prediction of microRNA binding sites","volume":"13","author":"Sticht","year":"2018","journal-title":"PLoS One"},{"key":"key20261020093159_b22-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","article-title":"miRDB: An online database for prediction of functional microRNA targets","volume":"48","author":"Chen","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"key20261020093159_b23-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"e05005","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"Elife"},{"key":"key20261020093159_b24-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"D93","DOI":"10.1093\/nar\/gkz881","article-title":"KnockTF: A comprehensive human gene expression profile database with knockdown\/knockout of transcription factors","volume":"48","author":"Feng","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"key20261020093159_b25-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/978-1-0716-2815-7_14","article-title":"MicroRNA regulatory network analysis using miRNet 2.0","volume":"2594","author":"Chang","year":"2023","journal-title":"Methods Mol Biol"},{"key":"key20261020093159_b26-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20261020093159_b27-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"e02979","DOI":"10.1002\/advs.202502979","article-title":"HLA-DR+ tumor cells show an association with a distinct immune microenvironment and CD8+ T-cell exhaustion in HBV-associated hepatocellular carcinoma","volume":"12","author":"Chang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"key20261020093159_b28-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12985-023-02253-2","article-title":"HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population","volume":"20","author":"Zhao","year":"2023","journal-title":"Virol J"},{"key":"key20261020093159_b29-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"2254239","DOI":"10.1080\/21645515.2023.2254239","article-title":"Identification of key immune cell-related genes involved in tumorigenesis and prognosis of cervical squamous cell carcinoma","volume":"19","author":"Yan","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"key20261020093159_b30-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1007\/s00018-019-03120-6","article-title":"Novel insights into PARPs in gene expression: Regulation of RNA metabolism","volume":"76","author":"Ke","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"key20261020093159_b31-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semcdb.2016.11.010","article-title":"PARP1 orchestrates epigenetic events setting up chromatin domains","volume":"63","author":"Ciccarone","year":"2017","journal-title":"Semin Cell Dev Biol"},{"key":"key20261020093159_b32-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines and the immune response to cancer","volume":"54","author":"Ozga","year":"2021","journal-title":"Immunity"},{"key":"key20261020093159_b33-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1016\/j.ccell.2024.10.008","article-title":"Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy","volume":"42","author":"Yang","year":"2024","journal-title":"Cancer Cell"},{"key":"key20261020093159_b34-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00262-024-03909-w","article-title":"CCR5 and IL-12 co-expression in CAR T cells improves antitumor efficacy by reprogramming tumor microenvironment in solid tumors","volume":"74","author":"Tian","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"key20261020093159_b35-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"7661","DOI":"10.1038\/s41467-023-43548-w","article-title":"ID1 expressing macrophages support cancer cell stemness and limit CD8+ T cell infiltration in colorectal cancer","volume":"14","author":"Shang","year":"2023","journal-title":"Nat Commun"},{"key":"key20261020093159_b36-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.4049\/jimmunol.1201018","article-title":"Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth","volume":"189","author":"Schlecker","year":"2012","journal-title":"J Immunol"},{"key":"key20261020093159_b37-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1158\/0008-5472.CAN-17-0348","article-title":"CCR5+ myeloid-derived suppressor cells are enriched and activated in melanoma lesions","volume":"78","author":"Blattner","year":"2018","journal-title":"Cancer Res"},{"key":"key20261020093159_b38-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1007\/s12094-022-02913-9","article-title":"Expression and potential role of CCL4 in CD8+T cells in NSCLC","volume":"24","author":"Chen","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"key20261020093159_b39-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1182\/blood-2008-04-154286","article-title":"Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation","volume":"112","author":"Arnold","year":"2008","journal-title":"Blood"},{"key":"key20261020093159_b40-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"13740","DOI":"10.1073\/pnas.1922884117","article-title":"HTLV-1 induces T cell malignancy and inflammation by viral antisense factor-mediated modulation of the cytokine signaling","volume":"117","author":"Higuchi","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20261020093159_b41-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/v8020034","article-title":"The role of HBZ in HTLV-1-induced oncogenesis","volume":"8","author":"Zhao","year":"2016","journal-title":"Viruses"},{"key":"key20261020093159_b42-ol-32-5-15852","doi-asserted-by":"publisher","first-page":"e1001274","DOI":"10.1371\/journal.ppat.1001274","article-title":"HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo","volume":"7","author":"Satou","year":"2011","journal-title":"PLoS Pathog"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:32:04Z","timestamp":1792477924000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9,8]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15852","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]}}}